Leju Intelligent Entrepreneurship Board IPO has been accepted for review, aiming to raise 2.6 billion yuan.
On May 19th, Leju Intelligent (Shenzhen) Co., Ltd. (referred to as Leju Intelligent) has submitted its application for an IPO on the ChiNext board of the Shenzhen Stock Exchange. Orient Securities is the sponsor institution, with plans to raise 2.6 billion yuan.
On May 19th, Leju Intelligent (Shenzhen) Co., Ltd. (hereinafter referred to as Leju Intelligent) IPO on the Shenzhen Stock Exchange's ChiNext board has been accepted. Orient is the sponsor institution, aiming to raise 2.6 billion yuan.
The prospectus shows that Leju Intelligent is a global leading intelligent technology enterprise specializing in the research and production of human-shaped Siasun Robot & Automation. The company focuses on the full-stack technology research and development, complete machine production and sales, as well as application solutions of human-shaped Siasun Robot & Automation "brain-little brain-body" system. The company has mastered core technologies in the field of human-shaped Siasun Robot & Automation, such as whole-body motion control algorithms, high-performance integrated joint design, and related technologies in intelligent technology.
The company's main business is the research, production, and sales of human-shaped Siasun Robot & Automation. The main products are human-shaped Siasun Robot & Automation, currently covering full-size and medium and small size product series, mainly the Kuavo series, Roban series, and Aelos series. In addition to human-shaped Siasun Robot & Automation, the company also has other intelligent products for programming education and medical services.
The Kuavo series is the company's key research and development product, which is the core strategic product explored by the company in the field of artificial intelligence and intelligent technology. It has been applied in multiple scenarios such as scientific research education, commercial services, data collection, and industrial manufacturing.
The Roban series is the company's key platform for the research and education of medium and small-sized human-shaped Siasun Robot & Automation, which is the key product launched by the company for research and education in the field of artificial intelligence and intelligent technology. It has been widely applied in research and development, practical education, and other research and education scenarios.
The Aelos series is a small human-shaped Siasun Robot & Automation launched by the company for popularizing basic artificial intelligence education, which is the cornerstone product of the company's AI education product series for the entire education stage, covering different levels of artificial intelligence programming education needs in primary and secondary schools, vocational middle schools, and colleges.
Among other intelligent products, Cube and Pando are intelligent products launched by the company for children's artificial intelligence enlightenment education. Together with the Roban series and Aelos series, they form a complete lineup of the company's artificial intelligence education products, meeting the teaching needs of artificial intelligence across all educational levels. Fluvo is a product that the company is exploring and applying in the field of medical scenarios.
After deducting the issuance expenses from the proceeds raised in this offering, they will be invested in the following projects:
Financially, in the fiscal years 2023, 2024, and 2025, Leju Intelligent's operating income is expected to be approximately 53.9883 million yuan, 55.5003 million yuan, and 258 million yuan, respectively; during the same period, the net profit is estimated to be approximately -41.1161 million yuan, -60.1287 million yuan, and -71.2458 million yuan, respectively.
Related Articles

New Stock Outlook | Cutting Costs, Pressuring Costs, Losing Customers Three Major Cracks Behind the Silicon-Based Intelligent Light Ring

Industrial: Compared to the dot-com bubble, where is the current AI market heading?

New Stock News | Rongtai Pharmaceutical submits a second application to the Hong Kong Stock Exchange, becoming China's third-largest provider of digital marketing and supply chain services for the outpatient pharmaceutical market.
New Stock Outlook | Cutting Costs, Pressuring Costs, Losing Customers Three Major Cracks Behind the Silicon-Based Intelligent Light Ring

Industrial: Compared to the dot-com bubble, where is the current AI market heading?

New Stock News | Rongtai Pharmaceutical submits a second application to the Hong Kong Stock Exchange, becoming China's third-largest provider of digital marketing and supply chain services for the outpatient pharmaceutical market.






